The launch represents a significant expansion of the company’s business interests and comes as pharmaceutical companies ...

Ionis Pharmaceuticals has received US FDA approval for zilganersen (Zanvastro) to treat Alexander disease, a rare and ...

The analysis is based on diagnostic testing trends across its network and tracks changes in disease positivity and geographic ...

The collaboration is aimed at accelerating some of the most time-intensive regulatory work in drug development ...

This, with its wholly owned subsidiary, RPG Active Pharma Limited (RPGAP), agreeing to acquire the API and intermediates ...

The technologies combine machine learning, deep learning and 3D imaging to support clinicians in identifying chronic kidney ...

The certification was issued following an audit by SGS, an independent testing, inspection and certification company, and ...

The report examines how changing cultural attitudes toward beauty and aging are reshaping the aesthetic treatment landscap ...

Priority-reviewed topical JAK inhibitor now approved for children as young as two, backed by Phase III data showing 63% ...

The campaign combines Fortis Healthcare’s clinical expertise and hospital network with Takeda’s scientific expertise in ...

The discussions will examine how quality systems can move beyond compliance to become more predictive, risk-based and capable ...

The completion of the Apogee acquisition is an important step in further strengthening AbbVie's leadership in immunology and ...